Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
2013 · Journal of Clinical Oncology · 1,059 citations
https://doi.org/10.1200/jco.2013.49.6968
T
Terri S. Armstrong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
601
Papers
16.1K
Citations
55
h-index
171
i10-index
Terri S. Armstrong is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Cancer-related cognitive impairment studies. The author has an h-index of 55, co-authored 511 publications.
ORCID: 0000-0002-2414-0492Papers by this author
worksPolymorphisms of <i>LIG4, BTBD2, HMGA2</i>, and <i>RTEL1</i> Genes Involved in the Double-Strand Break Repair Pathway Predict Glioblastoma Survival
2010 · Journal of Clinical Oncology · 112 citations
https://doi.org/10.1200/jco.2009.26.6213
Risk factors for fatigue severity in primary brain tumor patients
2010 · Cancer · 102 citations
https://doi.org/10.1002/cncr.25018
1,000,000 cases of COVID-19 outside of China: The date predicted by a simple heuristic
2020 · Global Epidemiology · 51 citations
https://doi.org/10.1016/j.gloepi.2020.100023
Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2020 · Future Oncology · 34 citations
https://doi.org/10.2217/fon-2020-0094
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
2022 · Critical Reviews in Oncology/Hematology · 28 citations
https://doi.org/10.1016/j.critrevonc.2022.103822
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat